SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels

Genes Chromosomes and Cancer

Volumn 53, Issue 2, 2014, Pages 168-176

  Papp, Gergo ^a   Krausz, Thomas ^b   Stricker, Thomas P ^c   Szendroi, Miklós ^a   Sápi, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FORMALDEHYDE; MESSENGER RNA; MICRORNA; MICRORNA 206; MICRORNA 381; MICRORNA 671 5P; SMARCB1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COMPUTER MODEL; CONTROLLED STUDY; EPITHELIOID SARCOMA; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEOPLASM; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; STAINING;

CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, MESSENGER; SARCOMA; TRANSCRIPTION FACTORS;

EID: 84890120594     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22128     Document Type: Article

References (50)

1. Armeanu-Ebinger S, Herrmann D, Bonin M, Leuschner I, Warmann SW, Fuchs J, Seitz G. 2012. Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. Exp Cell Res 318:2567-2577.
2. Arnold MA, Arnold CA, Li G, Chae U, El-Etriby R, Lee CC, Tsokos M. 2013. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics. Hum Pathol 44:881-887.
3. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. 1999. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74-79.
4. Borjigin N, Ohno S, Wu W, Tanaka M, Suzuki R, Fujita K, Takanashi M, Oikawa K, Goto T, Motoi T, Kosaka T, Yamamoto K, Kuroda M. 2012. TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma. Biochem Biophys Res Commun 427:355-360.
5. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999-3004.
6. Chase DR, Enzinger FM. 1985. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 9:241-263.
7. Chbani L, Guillou L, Terrier P, Decouvelaere AV, Gregoire F, Terrier-Lacombe MJ, Ranchere D, Robin YM, Collin F, Freneaux P, Coindre JM. 2009. Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group. Am J Clin Pathol 131:222-227.
8. Chen L, Wang Q, Wang GD, Wang HS, Huang Y, Liu XM, Cai XH. 2013. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. FEBS Lett 587:1366-1372.
9. Chen X, Yan Q, Li S, Zhou L, Yang H, Yang Y, Liu X, Wan X. 2012. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett 314:41-53.
10. Cho WC. 2007. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60.
11. Dei Tos AP, Wagner AJ, Modena P, Comandone A, Leyvraz S. 2009. Epithelioid soft tissue tumors. Semin Oncol 36:347-357.
12. Deng S, Calin GA, Croce CM, Coukos G, Zhang L. 2008. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7:2643-2646.
13. Djuranovic S, Nahvi A, Green R. 2011. A parsimonious model for gene regulation by miRNAs. Science 331:550-553.
14. Dylla L, Moore C, Jedlicka P. 2013. MicroRNAs in Ewing Sarcoma. Front Oncol 3:65.
15. Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G. 2012. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 12:27-33.
16. Gasparini P, Facchinetti F, Boeri M, Lorenzetto E, Livio A, Gronchi A, Ferrari A, Massimino M, Spreafico F, Giangaspero F, Forni M, Maestro R, Alaggio R, Pilotti S, Collini P, Modena P, Sozzi G. 2011. Prognostic determinants in epithelioid sarcoma. Eur J Cancer 47:287-295.
17. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835-840.
18. Hisaoka M, Matsuyama A, Nagao Y, Luan L, Kuroda T, Akiyama H, Kondo S, Hashimoto H. 2011. Identification of altered MicroRNA expression patterns in synovial sarcoma. Genes Chromosomes Cancer 50:137-145.
19. Hollmann TJ, Hornick JL. 2011. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 35:e47-63.
20. Hornick JL, Dal Cin P, Fletcher CD. 2009. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol 33:542-550.
21. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070.
22. Italiano A, Thomas R, Breen M, Zhang L, Crago AM, Singer S, Khanin R, Maki RG, Mihailovic A, Hafner M, Tuschl T, Antonescu CR. 2012. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification. Genes Chromosomes Cancer 51:569-578.
23. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. 2004. Human microRNA targets. PLoS Biol 2:e363.
24. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. 1994. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266:2002-2006.
25. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. 2007. The role of site accessibility in microRNA target recognition. Nat Genet 39:1278-1284.
26. Kohashi K, Izumi T, Oda Y, Yamamoto H, Tamiya S, Taguchi T, Iwamoto Y, Hasegawa T, Tsuneyoshi M. 2009. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum Pathol 40:349-355.
27. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. 2008. miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res 68:5004-5008.
28. Lee RC, Ambros V. 2001. An extensive class of small RNAs in caenorhabditis elegans. Science 294:862-864.
29. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787-798.
30. Li L, Sarver AL, Alamgir S, Subramanian S. 2012. Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Lab Invest 92:571-583.
31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
32. Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K, Renard M, Sciot R, Rao P, Oberlin O, Delattre O, Shipley J. 2010. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer 102:1769-1777.
33. Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, Sozzi G. 2005. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 65:4012-4019.
34. Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S, Suzuki M, Yoshino I, Seki N. 2012. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet 57:38-45.
35. Nohata N, Hanazawa T, Enokida H, Seki N. 2012. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 3:9-21.
36. Papp G, Changchien YC, Peterfia B, Pecsenka L, Krausz T, Stricker TP, Khoor A, Donner L, Sapi Z. 2013. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma. Mod Pathol 26:393-403.
37. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517.
38. Reisman D, Glaros S, Thompson EA. 2009. The SWI/SNF complex and cancer. Oncogene 28:1653-1668.
39. Ross HM, Lewis JJ, Woodruff JM, Brennan MF. 1997. Epithelioid sarcoma: clinical behavior and prognostic factors of survival. Ann Surg Oncol 4:491-495.
40. Rothschild SI, Tschan MP, Jaggi R, Fey MF, Gugger M, Gautschi O. 2012. MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma. J Thorac Oncol 7:1069-1077.
41. Sarver AL, Subramanian S. 2012. Competing endogenous RNA database. Bioinformation 8:731-733.
42. Song G, Zhang Y, Wang L. 2009. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 284:31921-31927.
43. Subramanian S, Kartha RV. 2012. MicroRNA-mediated gene regulations in human sarcomas. Cell Mol Life Sci 69:3571-3585.
44. Sullivan LM, Folpe AL, Pawel BR, Judkins AR, Biegel JA. 2013. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod Pathol 26:385-392.
45. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756.
46. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, Tuschl T, Ponzetto C. 2009. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 119:2366-2378.
47. Townley-Tilson WH, Callis TE, Wang D. 2010. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 42:1252-1255.
48. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206.
49. Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I, Raap AK, Verrijzer CP. 2005. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19:665-670.
50. Wang X. 2008. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14:1012-1017.